Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 203

Stilla gets $18m series A result

Illumina Ventures and BNP Paribas Développement have backed a series A round which will help the biotechnology company expand sales and launch a new product.

Nov 26, 2018

Botkeeper brings $18m on board

Google's Gradient Ventures unit was part of a series A round that will enable the automated bookkeeping company to expand its team and bolster its marketing efforts.

Nov 26, 2018

Kanova captures $16.6m series A

Legend-backed biotherapeutics developer Kanova has secured capital from investors including Tsinghua University-managed Lotus Lake Ventures.

Nov 26, 2018

Elens articulates $21.6m

Provided by Matrix Partner China and Ceyuan Ventures, the series A capital will help Renmin natural language processing spinout Elens mature its product development and R&D capabilities.

Nov 26, 2018

Corporate venturing deal net: 19-23 November 2018

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Nov 23, 2018

OMass amasses $17.9m series A

Oxford spinout OMass has pivoted from offering consulting services to developing its own drugs after closing a series A round backed by Oxford Sciences Innovation.

Nov 22, 2018

Corporates take Leap in $288m series A

Leap Motor has received $288m in a round co-led by Shanghai Electric and CRRC as it prepares to launch its smart electric sports car early next year.

Nov 20, 2018

Xiaoqule bands together investors to raise $108m

The community-focused e-commerce platform has raised series A funds from investors including Ping An Ventures and SIG Asia.

Nov 20, 2018

Corporate venturing deal net: 12-16 November 2018

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Nov 16, 2018

Ribometrix rips $30m in Merck-led round

M Ventures led a series A round for UNC's RNA therapy spinout, while Amgen, Illumina, AbbVie and Mitsubishi Tanabe Pharma also took part.

Nov 16, 2018
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here